Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

By sjmartinez • February 24, 2023

Sofen H, Bissonnette R, Yosipovitch G, Silverberg JI, Tyring S, Loo WJ, Zook M, Lee M, Zou L, Jiang GL, Paolini JF. Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study. EClinicalMedicine. 2023 Feb 3;57:101826. doi: 10.1016/j.eclinm.2023.101826. PMID: 36816342; PMCID: PMC9932343.

Tags: Dermatology, Olive View DoM, Publications

Epigenetic age and accelerated aging phenotypes: a tumor biomarker for predicting colorectal cancer

Jung SY, Pellegrini M, Tan X, Yu H. Epigenetic age and accelerated aging phenotypes: a tumor biomarker for predicting colorectal cancer. Aging (Albany NY). 2025[...]

Macrophage-derived Spp1 promotes intramuscular fat in dystrophic muscle

Farahat PK, Kumagai-Cresse C, Aragón RL, Ma F, Amakor JK, Espinoza A, Kramerova I, Jimenez RJ, Smith BM, Perez J, Crosbie RH, Nagendra AH, McCourt-Towner[...]

AI-Assisted Billing in Dermatologic Surgery: Evaluating ChatGPT’s and Gemini’s Accuracy in CPT Code Assignment

Modiri O, Ebriani J, Jairath N, Lewin J. AI-Assisted Billing in Dermatologic Surgery: Evaluating ChatGPT's and Gemini's Accuracy in CPT Code Assignment. Dermatol Surg. 2025[...]